j&j

AMA Update 99: Andrea Garcia, JD, MPH, discusses legal challenges to Biden’s vaccine requirements

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering legal challenges to the Biden administration’s recent vaccine requirements for large companies and health workers, as well as ongoing efforts to vaccinate the nation’s 5 to 11 year olds.

Read More

AMA Update 94: Dr. Sandra Fryhofer shares the latest on boosters and the new «mix-and-match strategy»

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

Read More

AMA Update 93: Andrea Garcia, JD, MPH, discusses boosters and pending authorizations

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

Read More

AMA Update 89: Andrea Garcia, JD, MPH, discusses trends and urgent call for pregnant people to get vaccinated

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering movement on FDA’s J&J and Moderna booster EUA consideration, New York’s vaccine mandate, and Merck’s antiviral COVID-19 treatment pill.

Read More

AMA Update 28: Pausing the J&J vaccine: liaison shares what physicians need to know

Friend of the show, Dr. Sandra Fryhofer—the AMA liaison to the CDC’s Advisory Committee on Immunization Practices and the AMA’s representative on the COVID-19 vaccine work group—joins us for a quick and comprehensive look at the emerging details regarding the J&J/Janssen COVID-19 vaccine.

Read More